All In Biotech

Free tool

FAERS Monitor: Zunveyl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218549 or its brand name (Zunveyl, Benzgalantamine Gluconate). Reports on generic versions are filed under their own applications.

Reports

82

Serious

17

21% of reports

Hospitalization

6

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • agitation7
  • weight decreased7
  • confusional state6
  • somnolence6
  • aggression5
  • urinary tract infection5
  • fall4
  • pruritus4
  • sedation4
  • tremor4
  • decreased appetite3
  • gait disturbance3
  • hallucination3
  • rash3
  • scratch3

Reports by year received

View as table
YearReports
202536
202646

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,077 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
scratchSignal373.024.0147
sedationSignal439.215.1113
aggressionSignal525.611.095
agitationSignal724.512.0135
hallucinationSignal310.23.417
confusional stateSignal69.54.438
somnolenceSignal67.63.529
urinary tract infectionSignal57.53.222
weight decreasedSignal76.43.227
tremorSignal46.22.413
gait disturbanceSignal34.01.34
decreased appetite33.31.13
fall43.11.24
pruritus42.71.03
rash31.80.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.